Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by Garp1on Sep 15, 2011 7:41am

268 Views

Post# 19044236

RE: RE: RE: RE: Huss

For somebody whom had dinner with these peoples, It looks like they had nothing to say to you. I get no sense of vision, no feeling about is own company, no comments about why the market trades TH at such a discounted price, no strategy about how they can counter this, no comments about being on track in yheir sales and strategy. I can understand not talking about material information but it would seem you only had dinner and that was it. About shooting himself in the foot, unless he stood up and was not limping, I would not conclude that he did not do it.

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price